Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe

C. Thorne, M. L. Newell, A. Bailey, C. S. Peckham, C. Giaquinto, E. Ruga, A. De Rossi, D. Truscia, I. Grosch-Worner, A. Schafer, J. Mok, F. Johnstone, F. Omenaca, J. Jiminez, C. De Alba, M. C. Garcia-Rodriguez, I. Bates, I. De Jose, F. Hawkins, R. Martinez ZapicoF. Asensi-Botet, M. C. Otero, D. Perez-Tamarit, A. Gonzalez Molina, H. Canosa, H. Scherpbier, K. Boer, A. B. Bohlin, S. Lindgren, E. Belfrage, J. Levy, A. Alimenti, P. Barlow, A. Ferrazin, A. Dre Maria, C. Gotta, V. Maritati, A. Mur, M. T. Rovira, A. Paya, O. Coll, C. Fortuny, J. Boguna, M. Casellas Caro, Y. Canet, G. Pardi, A. E. Semprini, M. Ravizza, C. Castagna, S. Fiore, B. Guerra, S. Bianchi, L. Bovicelli, E. Prati, S. Zanelli, M. Duse, A. Soresina, G. Scaravelli, M. Stegagno, M. De Santis, M. L. Muggiasca, P. Marchisio, A. Iasci, A. Spinillo, A. Bucceri, E. Grossi, L. Rancilio, R. Smith, A. M. Lewis

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objectives - To document policies regarding the use of interventions to reduce risk of vertical transmission of human immunodeficiency virus (HIV) and assess the extent of changes since 1994. Design - A postal questionnaire survey and data from the European Collaborative Study (ECS), a prospective multi-centre cohort study. Setting - Fifty-four obstetric centres in 16 European countries. Sample - A questionnaire response from 54 obstetricians; 669 deliveries to HIV-infected women enrolled in the ECS from 1994 to 1997. Main outcome measures - Use of zidovudine during pregnancy, at delivery and to the neonate; caesarean section delivery rates; vaginal lavage; avoidance of breastfeeding; vertical transmission rate. Results - Zidovudine therapy to reduce vertical transmission is now widespread in Europe and routine in all but one centre surveyed, although regimens vary. In 11 (26%) centres elective caesarean section is offered to-all HIV-infected women and a further nine (21%) have a policy of routine vaginal lavage. In all centres HIV-infected women are advised to avoid breastfeeding. In the ECS there has been a significant temporal decline in the vertical transmission rate with an increase in zidovudine use. More than 90% of women in the ECS who were delivered in 1997 received one or more components of zidovudine therapy; the rate of vertical transmission is 9% where zidovudine has been used, compared with 15% without use of zidovudine. Conclusions - Although the use of zidovudine to reduce vertical transmission is increasing in Europe and, with the avoidance of breastfeeding, is associated with a decline in vertical transmission, the success of these interventions will be limited by the uptake of antenatal screening.

Original languageEnglish
Pages (from-to)704-709
Number of pages6
JournalBritish Journal of Obstetrics and Gynaecology
Volume105
Issue number7
Publication statusPublished - 1998

Fingerprint

Zidovudine
HIV-1
Mothers
Vaginal Douching
Breast Feeding
HIV
Cesarean Section
Therapeutics
Prenatal Diagnosis
Obstetrics
Cohort Studies
Outcome Assessment (Health Care)
Newborn Infant
Prospective Studies
Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Thorne, C., Newell, M. L., Bailey, A., Peckham, C. S., Giaquinto, C., Ruga, E., ... Lewis, A. M. (1998). Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. British Journal of Obstetrics and Gynaecology, 105(7), 704-709.

Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. / Thorne, C.; Newell, M. L.; Bailey, A.; Peckham, C. S.; Giaquinto, C.; Ruga, E.; De Rossi, A.; Truscia, D.; Grosch-Worner, I.; Schafer, A.; Mok, J.; Johnstone, F.; Omenaca, F.; Jiminez, J.; De Alba, C.; Garcia-Rodriguez, M. C.; Bates, I.; De Jose, I.; Hawkins, F.; Martinez Zapico, R.; Asensi-Botet, F.; Otero, M. C.; Perez-Tamarit, D.; Gonzalez Molina, A.; Canosa, H.; Scherpbier, H.; Boer, K.; Bohlin, A. B.; Lindgren, S.; Belfrage, E.; Levy, J.; Alimenti, A.; Barlow, P.; Ferrazin, A.; Dre Maria, A.; Gotta, C.; Maritati, V.; Mur, A.; Rovira, M. T.; Paya, A.; Coll, O.; Fortuny, C.; Boguna, J.; Casellas Caro, M.; Canet, Y.; Pardi, G.; Semprini, A. E.; Ravizza, M.; Castagna, C.; Fiore, S.; Guerra, B.; Bianchi, S.; Bovicelli, L.; Prati, E.; Zanelli, S.; Duse, M.; Soresina, A.; Scaravelli, G.; Stegagno, M.; De Santis, M.; Muggiasca, M. L.; Marchisio, P.; Iasci, A.; Spinillo, A.; Bucceri, A.; Grossi, E.; Rancilio, L.; Smith, R.; Lewis, A. M.

In: British Journal of Obstetrics and Gynaecology, Vol. 105, No. 7, 1998, p. 704-709.

Research output: Contribution to journalArticle

Thorne, C, Newell, ML, Bailey, A, Peckham, CS, Giaquinto, C, Ruga, E, De Rossi, A, Truscia, D, Grosch-Worner, I, Schafer, A, Mok, J, Johnstone, F, Omenaca, F, Jiminez, J, De Alba, C, Garcia-Rodriguez, MC, Bates, I, De Jose, I, Hawkins, F, Martinez Zapico, R, Asensi-Botet, F, Otero, MC, Perez-Tamarit, D, Gonzalez Molina, A, Canosa, H, Scherpbier, H, Boer, K, Bohlin, AB, Lindgren, S, Belfrage, E, Levy, J, Alimenti, A, Barlow, P, Ferrazin, A, Dre Maria, A, Gotta, C, Maritati, V, Mur, A, Rovira, MT, Paya, A, Coll, O, Fortuny, C, Boguna, J, Casellas Caro, M, Canet, Y, Pardi, G, Semprini, AE, Ravizza, M, Castagna, C, Fiore, S, Guerra, B, Bianchi, S, Bovicelli, L, Prati, E, Zanelli, S, Duse, M, Soresina, A, Scaravelli, G, Stegagno, M, De Santis, M, Muggiasca, ML, Marchisio, P, Iasci, A, Spinillo, A, Bucceri, A, Grossi, E, Rancilio, L, Smith, R & Lewis, AM 1998, 'Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe', British Journal of Obstetrics and Gynaecology, vol. 105, no. 7, pp. 704-709.
Thorne, C. ; Newell, M. L. ; Bailey, A. ; Peckham, C. S. ; Giaquinto, C. ; Ruga, E. ; De Rossi, A. ; Truscia, D. ; Grosch-Worner, I. ; Schafer, A. ; Mok, J. ; Johnstone, F. ; Omenaca, F. ; Jiminez, J. ; De Alba, C. ; Garcia-Rodriguez, M. C. ; Bates, I. ; De Jose, I. ; Hawkins, F. ; Martinez Zapico, R. ; Asensi-Botet, F. ; Otero, M. C. ; Perez-Tamarit, D. ; Gonzalez Molina, A. ; Canosa, H. ; Scherpbier, H. ; Boer, K. ; Bohlin, A. B. ; Lindgren, S. ; Belfrage, E. ; Levy, J. ; Alimenti, A. ; Barlow, P. ; Ferrazin, A. ; Dre Maria, A. ; Gotta, C. ; Maritati, V. ; Mur, A. ; Rovira, M. T. ; Paya, A. ; Coll, O. ; Fortuny, C. ; Boguna, J. ; Casellas Caro, M. ; Canet, Y. ; Pardi, G. ; Semprini, A. E. ; Ravizza, M. ; Castagna, C. ; Fiore, S. ; Guerra, B. ; Bianchi, S. ; Bovicelli, L. ; Prati, E. ; Zanelli, S. ; Duse, M. ; Soresina, A. ; Scaravelli, G. ; Stegagno, M. ; De Santis, M. ; Muggiasca, M. L. ; Marchisio, P. ; Iasci, A. ; Spinillo, A. ; Bucceri, A. ; Grossi, E. ; Rancilio, L. ; Smith, R. ; Lewis, A. M. / Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. In: British Journal of Obstetrics and Gynaecology. 1998 ; Vol. 105, No. 7. pp. 704-709.
@article{eb4cdc8b43964d928be6d1ecc50b806a,
title = "Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe",
abstract = "Objectives - To document policies regarding the use of interventions to reduce risk of vertical transmission of human immunodeficiency virus (HIV) and assess the extent of changes since 1994. Design - A postal questionnaire survey and data from the European Collaborative Study (ECS), a prospective multi-centre cohort study. Setting - Fifty-four obstetric centres in 16 European countries. Sample - A questionnaire response from 54 obstetricians; 669 deliveries to HIV-infected women enrolled in the ECS from 1994 to 1997. Main outcome measures - Use of zidovudine during pregnancy, at delivery and to the neonate; caesarean section delivery rates; vaginal lavage; avoidance of breastfeeding; vertical transmission rate. Results - Zidovudine therapy to reduce vertical transmission is now widespread in Europe and routine in all but one centre surveyed, although regimens vary. In 11 (26{\%}) centres elective caesarean section is offered to-all HIV-infected women and a further nine (21{\%}) have a policy of routine vaginal lavage. In all centres HIV-infected women are advised to avoid breastfeeding. In the ECS there has been a significant temporal decline in the vertical transmission rate with an increase in zidovudine use. More than 90{\%} of women in the ECS who were delivered in 1997 received one or more components of zidovudine therapy; the rate of vertical transmission is 9{\%} where zidovudine has been used, compared with 15{\%} without use of zidovudine. Conclusions - Although the use of zidovudine to reduce vertical transmission is increasing in Europe and, with the avoidance of breastfeeding, is associated with a decline in vertical transmission, the success of these interventions will be limited by the uptake of antenatal screening.",
author = "C. Thorne and Newell, {M. L.} and A. Bailey and Peckham, {C. S.} and C. Giaquinto and E. Ruga and {De Rossi}, A. and D. Truscia and I. Grosch-Worner and A. Schafer and J. Mok and F. Johnstone and F. Omenaca and J. Jiminez and {De Alba}, C. and Garcia-Rodriguez, {M. C.} and I. Bates and {De Jose}, I. and F. Hawkins and {Martinez Zapico}, R. and F. Asensi-Botet and Otero, {M. C.} and D. Perez-Tamarit and {Gonzalez Molina}, A. and H. Canosa and H. Scherpbier and K. Boer and Bohlin, {A. B.} and S. Lindgren and E. Belfrage and J. Levy and A. Alimenti and P. Barlow and A. Ferrazin and {Dre Maria}, A. and C. Gotta and V. Maritati and A. Mur and Rovira, {M. T.} and A. Paya and O. Coll and C. Fortuny and J. Boguna and {Casellas Caro}, M. and Y. Canet and G. Pardi and Semprini, {A. E.} and M. Ravizza and C. Castagna and S. Fiore and B. Guerra and S. Bianchi and L. Bovicelli and E. Prati and S. Zanelli and M. Duse and A. Soresina and G. Scaravelli and M. Stegagno and {De Santis}, M. and Muggiasca, {M. L.} and P. Marchisio and A. Iasci and A. Spinillo and A. Bucceri and E. Grossi and L. Rancilio and R. Smith and Lewis, {A. M.}",
year = "1998",
language = "English",
volume = "105",
pages = "704--709",
journal = "British Journal of Obstetrics and Gynaecology",
issn = "0306-5456",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe

AU - Thorne, C.

AU - Newell, M. L.

AU - Bailey, A.

AU - Peckham, C. S.

AU - Giaquinto, C.

AU - Ruga, E.

AU - De Rossi, A.

AU - Truscia, D.

AU - Grosch-Worner, I.

AU - Schafer, A.

AU - Mok, J.

AU - Johnstone, F.

AU - Omenaca, F.

AU - Jiminez, J.

AU - De Alba, C.

AU - Garcia-Rodriguez, M. C.

AU - Bates, I.

AU - De Jose, I.

AU - Hawkins, F.

AU - Martinez Zapico, R.

AU - Asensi-Botet, F.

AU - Otero, M. C.

AU - Perez-Tamarit, D.

AU - Gonzalez Molina, A.

AU - Canosa, H.

AU - Scherpbier, H.

AU - Boer, K.

AU - Bohlin, A. B.

AU - Lindgren, S.

AU - Belfrage, E.

AU - Levy, J.

AU - Alimenti, A.

AU - Barlow, P.

AU - Ferrazin, A.

AU - Dre Maria, A.

AU - Gotta, C.

AU - Maritati, V.

AU - Mur, A.

AU - Rovira, M. T.

AU - Paya, A.

AU - Coll, O.

AU - Fortuny, C.

AU - Boguna, J.

AU - Casellas Caro, M.

AU - Canet, Y.

AU - Pardi, G.

AU - Semprini, A. E.

AU - Ravizza, M.

AU - Castagna, C.

AU - Fiore, S.

AU - Guerra, B.

AU - Bianchi, S.

AU - Bovicelli, L.

AU - Prati, E.

AU - Zanelli, S.

AU - Duse, M.

AU - Soresina, A.

AU - Scaravelli, G.

AU - Stegagno, M.

AU - De Santis, M.

AU - Muggiasca, M. L.

AU - Marchisio, P.

AU - Iasci, A.

AU - Spinillo, A.

AU - Bucceri, A.

AU - Grossi, E.

AU - Rancilio, L.

AU - Smith, R.

AU - Lewis, A. M.

PY - 1998

Y1 - 1998

N2 - Objectives - To document policies regarding the use of interventions to reduce risk of vertical transmission of human immunodeficiency virus (HIV) and assess the extent of changes since 1994. Design - A postal questionnaire survey and data from the European Collaborative Study (ECS), a prospective multi-centre cohort study. Setting - Fifty-four obstetric centres in 16 European countries. Sample - A questionnaire response from 54 obstetricians; 669 deliveries to HIV-infected women enrolled in the ECS from 1994 to 1997. Main outcome measures - Use of zidovudine during pregnancy, at delivery and to the neonate; caesarean section delivery rates; vaginal lavage; avoidance of breastfeeding; vertical transmission rate. Results - Zidovudine therapy to reduce vertical transmission is now widespread in Europe and routine in all but one centre surveyed, although regimens vary. In 11 (26%) centres elective caesarean section is offered to-all HIV-infected women and a further nine (21%) have a policy of routine vaginal lavage. In all centres HIV-infected women are advised to avoid breastfeeding. In the ECS there has been a significant temporal decline in the vertical transmission rate with an increase in zidovudine use. More than 90% of women in the ECS who were delivered in 1997 received one or more components of zidovudine therapy; the rate of vertical transmission is 9% where zidovudine has been used, compared with 15% without use of zidovudine. Conclusions - Although the use of zidovudine to reduce vertical transmission is increasing in Europe and, with the avoidance of breastfeeding, is associated with a decline in vertical transmission, the success of these interventions will be limited by the uptake of antenatal screening.

AB - Objectives - To document policies regarding the use of interventions to reduce risk of vertical transmission of human immunodeficiency virus (HIV) and assess the extent of changes since 1994. Design - A postal questionnaire survey and data from the European Collaborative Study (ECS), a prospective multi-centre cohort study. Setting - Fifty-four obstetric centres in 16 European countries. Sample - A questionnaire response from 54 obstetricians; 669 deliveries to HIV-infected women enrolled in the ECS from 1994 to 1997. Main outcome measures - Use of zidovudine during pregnancy, at delivery and to the neonate; caesarean section delivery rates; vaginal lavage; avoidance of breastfeeding; vertical transmission rate. Results - Zidovudine therapy to reduce vertical transmission is now widespread in Europe and routine in all but one centre surveyed, although regimens vary. In 11 (26%) centres elective caesarean section is offered to-all HIV-infected women and a further nine (21%) have a policy of routine vaginal lavage. In all centres HIV-infected women are advised to avoid breastfeeding. In the ECS there has been a significant temporal decline in the vertical transmission rate with an increase in zidovudine use. More than 90% of women in the ECS who were delivered in 1997 received one or more components of zidovudine therapy; the rate of vertical transmission is 9% where zidovudine has been used, compared with 15% without use of zidovudine. Conclusions - Although the use of zidovudine to reduce vertical transmission is increasing in Europe and, with the avoidance of breastfeeding, is associated with a decline in vertical transmission, the success of these interventions will be limited by the uptake of antenatal screening.

UR - http://www.scopus.com/inward/record.url?scp=0031828153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031828153&partnerID=8YFLogxK

M3 - Article

C2 - 9692409

AN - SCOPUS:0031828153

VL - 105

SP - 704

EP - 709

JO - British Journal of Obstetrics and Gynaecology

JF - British Journal of Obstetrics and Gynaecology

SN - 0306-5456

IS - 7

ER -